Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enteric-coated Aspirin for Prevention of Postsurgical Recurrence and Metastasis in Asian Colorectal Cancer Patients (the APREMEC Trial): a Large-scale Multicenter Randomized Double-blind Placebo-controlled Trial

NCT02607072 is registered in ClinicalTrials.gov with The Fourth Affiliated Hospital of Anhui Medical University as lead sponsor.

NCT NCT02607072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02607072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enteric-coated Aspirin for Prevention of Postsurgical Recurrence and Metastasis in Asian Colorectal Cancer Patients (the APREMEC Trial): a Large-scale Multicenter Randomized Double-blind Placebo-controlled Trial
Lead sponsor
The Fourth Affiliated Hospital of Anhui Medical University
Phase
Phase 3
Overall status
Unknown status
Start date
October 31, 2015
Completion date
October 31, 2022
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer